Literature DB >> 2673461

Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.

W Bensinger1, F B Petersen, M Banaji, C D Buckner, R Clift, S J Slichter, R Storb, E D Thomas.   

Abstract

This retrospective study analysed factors affecting engraftment and transfusion requirements of platelets and red blood cells in 303 patients transplanted for acute non-lymphocytic leukemia in first remission from HLA-identical or one-antigen mismatched donors. Multivariant analysis showed that the most important factors affecting the speed of engraftment were drugs used for graft-versus-host disease (GVHD) prophylaxis, the development of acute GVHD and HLA matching. Factors affecting only granulocyte recovery included patient age and sex. The radiation regimen used for preparing patients affected the time to platelet independence. Patients transplanted in laminar airflow rooms took longer to achieve red cell independence and required more units of red cells and platelets than patients transplanted in regular rooms. In addition, ABO incompatibility affected red cell transfusion requirements while GVHD prophylaxis and acute GVHD influenced both red blood cells and platelet support.

Entities:  

Mesh:

Year:  1989        PMID: 2673461

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Blood transfusion in marrow graft recipients.

Authors:  P Pihlstedt; T Paulin; B Sundberg; B Nilsson; O Ringdén
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

2.  High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices.

Authors:  Azadeh Alikhani; Elena Y Korchagina; Alexander A Chinarev; Nicolai V Bovin; William J Federspiel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

3.  Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation.

Authors:  S Kaur; G Cooper; S Fakult; H M Lazarus
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.